International Journal of STD & AIDS 1990; 1: 126-128

SHORT PAPER

Characteristics of a population volunteering for human immunodeficiency virus immunization T U Westblom MDt, R B Belshe MDt, G J Gorse MOl, E L Anderson MDt, C F Berry RN1 and NIAID AIDS Clinical Trials Network? IMarshaIl University School of Medicine, Huntington, West Virginia; and 2Bethesda, Maryland, USA Summary: A total of 166 volunteers for an AIDS vaccine study (Vaxsyn'', baculovirus produced recombinant GP160; MicroGeneSys Inc, West Haven, Connecticut, USA) were interviewed and examined. Blood was collected for routine laboratory testing as well as T-cellcounts, HIV ELISA (EIA), Western blot (WB) and p24 Ag. Eighty-five men (mean age 22.2 years, range 18-42) and 81 women (mean age 23.9 years, range 17-50) volunteered; 130/166 (78%) were university students. Most had learned of the study from news media (55%), friends or workplace (37%). The most common causes for exclusion were the presence of indeterminate WB (26.5%) or a change of mind after the initial interview (24%). Other causes were abnormal cell count and differential (7.2%), elevated alanine aminotransferase (3.6%), positive hepatitis B antibody (3.6%), abnormal urinalysis (3.4%), recent venereal disease (3.0%), T4 cell count

Characteristics of a population volunteering for human immunodeficiency virus immunization. NIAID AIDS Clinical Trials Network.

A total of 166 volunteers for an AIDS vaccine study (Vaxsyn, baculovirus produced recombinant GP160; MicroGeneSys Inc, West Haven, Connecticut, USA) w...
253KB Sizes 0 Downloads 0 Views

Recommend Documents